Literature DB >> 10233254

Emotional dysfunction, child-family relationships and childhood atopic dermatitis.

S Howlett1.   

Abstract

A link between atopic dermatitis (AD) and emotional dysfunction is now well established but consideration of this has yet to be widely incorporated into clinical management. A biopsychosocial model of the mind-body interaction is considered in conjunction with the theory of childhood emotional development and the impact of a diseased skin, for its effect on a child growing up with AD. AD inevitably adds to the difficulties of parenting, so that parents and children may become locked into dysfunctional relationships. This adds to the stresses for all concerned, and may contribute to the deterioration of the child's skin condition as part of a psychosomatic vicious cycle. There is a strong indication that the psychological dimensions of AD should be taken into account as part of routine management. Further research will be needed to establish the effectiveness of any psychological intervention.

Entities:  

Mesh:

Year:  1999        PMID: 10233254     DOI: 10.1046/j.1365-2133.1999.02696.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  10 in total

Review 1.  Childhood atopic eczema.

Authors:  Ross St C Barnetson; Maureen Rogers
Journal:  BMJ       Date:  2002-06-08

2.  Disease severity and associated family impact in childhood atopic dermatitis.

Authors:  R Balkrishnan; T S Housman; C Carroll; S R Feldman; A B Fleischer
Journal:  Arch Dis Child       Date:  2003-05       Impact factor: 3.791

Review 3.  Stress and atopic dermatitis.

Authors:  Jenna Arndt; Nananamibia Smith; Francisco Tausk
Journal:  Curr Allergy Asthma Rep       Date:  2008-07       Impact factor: 4.806

4.  Psychodermatology: a guide to understanding common psychocutaneous disorders.

Authors:  Mohammad Jafferany
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

5.  Maternal sensitivity and social support protect against childhood atopic dermatitis.

Authors:  Nicole L Letourneau; Anita L Kozyrskyj; Nela Cosic; Henry N Ntanda; Lubna Anis; Martha J Hart; Tavis S Campbell; Gerald F Giesbrecht
Journal:  Allergy Asthma Clin Immunol       Date:  2017-05-26       Impact factor: 3.406

6.  Does stress increase the risk of atopic dermatitis in adolescents? results of the Korea Youth Risk Behavior Web-based Survey (KYRBWS-VI).

Authors:  Jeoung A Kwon; Eun-Cheol Park; Minjee Lee; Ki-Bong Yoo; Sohee Park
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

7.  Improvement in disease severity and pruritus outcomes with crisaborole ointment, 2%, by baseline atopic dermatitis severity in children and adolescents with mild-to-moderate atopic dermatitis.

Authors:  Lawrence F Eichenfield; Gil Yosipovitch; Linda F Stein Gold; Mizuho Kalabis; Chuanbo Zang; Bonnie Vlahos; Paul Sanders; Daniela E Myers; Andrew G Bushmakin; Joseph C Cappelleri; Melissa Olivadoti; Amy S Paller
Journal:  Pediatr Dermatol       Date:  2020-09-27       Impact factor: 1.588

8.  Cumulative exposure to maternal psychological distress in the prenatal and postnatal periods and atopic dermatitis in children: findings from the TMM BirThree Cohort Study.

Authors:  Chikana Kawaguchi; Keiko Murakami; Mami Ishikuro; Fumihiko Ueno; Aoi Noda; Tomomi Onuma; Fumiko Matsuzaki; Hirohito Metoki; Shinichi Kuriyama; Taku Obara
Journal:  BMC Pregnancy Childbirth       Date:  2022-03-24       Impact factor: 3.007

9.  The epidemiology of eczema in children and adults in England: A population-based study using primary care data.

Authors:  Simon de Lusignan; Helen Alexander; Conor Broderick; John Dennis; Andrew McGovern; Claire Feeney; Carsten Flohr
Journal:  Clin Exp Allergy       Date:  2020-11-26       Impact factor: 5.018

10.  Patterns and trends in eczema management in UK primary care (2009-2018): A population-based cohort study.

Authors:  Simon de Lusignan; Helen Alexander; Conor Broderick; John Dennis; Andrew McGovern; Clarie Feeney; Carsten Flohr
Journal:  Clin Exp Allergy       Date:  2020-11-23       Impact factor: 5.018

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.